Interim Efficacy Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Interim Efficacy Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Interim Efficacy Data Today - Breaking & Trending Today

NLS Pharmaceutics AG: NLS Pharmaceutics Announces Positive Interim Top-Line Data for Quilience (Mazindol ER) in Patients with Narcolepsy

Published: March 16, 2022

Clinically meaningful results with Mazindol ER exhibiting a 39% reduction in ESS from baseline (-4.3 points placebo-adjusted); confirms statistical powering of the ongoing Phase 2a trialSafety and tolerability

Source: finanznachrichten.de

Related Topics:

United StatesAlex ZwyerEric KonofalKostenloser WertpapierhandelBruce CorserCindy RizzoPascal NigenWorld Sleep CongressWorld Sleep SocietyResearch ScientistsInternational Study GroupPharmaceutics LtdExchange CommissionAlpha BronzeCommittee For Medicinal Products HumanManagement InstituteEuropean Medicines Agency Review Of PitolisantWorld SleepInterim Efficacy DataEpworth Sleepiness ScaleSleepiness ScaleTotal ScoreLast VisitTolerability DataMedical Director

NLS Pharmaceutics Announces Positive Interim Top-Line Data for Quilience(R) (Mazindol ER) in Patients with Narcolepsy

Published: March 16, 2022

Press release content from Accesswire. The AP news staff was not involved in its creation.

Source: apnews.com

Related Topics:

United StatesAlex ZwyerEric KonofalBruce CorserCindy RizzoPascal NigenWorld Sleep CongressWorld Sleep SocietyResearch ScientistsPharmaceutics LtdExchange CommissionAlpha BronzeManagement InstituteWorld SleepInterim Efficacy DataEpworth Sleepiness ScaleSleepiness ScaleTotal ScoreLast VisitTolerability DataMedical DirectorCincinnati Based Sleep Management InstituteOpen Label ExtensionChief Executive OfficerScientific Officer